Skip to main content
. Author manuscript; available in PMC: 2018 May 1.
Published in final edited form as: Anesth Analg. 2017 May;124(5):1603–1610. doi: 10.1213/ANE.0000000000002021

Table 2.

Descriptive Statistics (Dose, Age, BMI)

Cumulative Drug Dose Final Effect Site Concentration Age BMI

Dexmedetomidine 0.5 (0.2) mg 26.2 (8.2) ng/ml 24.8 (6.3) yrs 25.1 (4.8) kg/m2
Midazolam 4.4 (2.2) mg 87.9 (43.9) ng/ml 23.9 (4.4) yrs 27.7 (5.6) kg/m2
Propofol 186 (77.5) mg 93.0 (38.8) mcg/ml 28.4 (5.4) yrs 26.1 (3.5) kg/m2
Control NA NA 26.5 (5.1) yrs 22.8 (2.7) kg/m2

Data presented as means and standard deviation, provided in parenthesis. Cumulative Drug Dose refers to the sedative dose administered to a participant over the course of the study. Final Effect Site Concentration refers to the effect site concentration of sedation drug at the end of the fMRI scan under sedation. BMI … body mass index. yrs … years.